Similar articles

• [Anti-H2 and omeprazole in brief therapy of peptic ulcer].

  Piai G, Sabbatini F, Mazzacca G. Piai G, et al. Ann Ital Chir. 1990 Jan-Feb;61(1):11-4. Ann Ital Chir. 1990. PMID: 1978622 Clinical Trial. Italian. No abstract available.
• [Strong inhibition of gastric acid secretion: when is it justifiable?].

  Dobrilla G, Amplaz S, Benvenuti S, Bertozzo A. Dobrilla G, et al. G Clin Med. 1990 Aug-Sep;71(8-9):521-6. G Clin Med. 1990. PMID: 1980653 Clinical Trial. Italian. No abstract available.
• [Omeprazole in the therapy of acid-induced diseases].

  Simon B, Dammann HG, Müller P. Simon B, et al. Z Gastroenterol. 1987 Aug;25 Suppl 3:146-51. Z Gastroenterol. 1987. PMID: 2889299 Clinical Trial. German.
• [Omeprazole. Its pharmacology and therapeutic efficacy].

  Protzer U, Holtermüller KH. Protzer U, et al. Dtsch Med Wochenschr. 1993 Feb 19;118(7):230-9. doi: 10.1055/s-2008-1059322. Dtsch Med Wochenschr. 1993. PMID: 8440164 Review. German. No abstract available.
• Omeprazole.

  Walan A. Walan A. Baillieres Clin Gastroenterol. 1988 Jul;2(3):629-40. doi: 10.1016/s0950-3528(88)80010-1. Baillieres Clin Gastroenterol. 1988. PMID: 3048454 Review. No abstract available.